These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3512593)

  • 1. Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Kato K; Shima K
    J Clin Endocrinol Metab; 1986 Apr; 62(4):783-4. PubMed ID: 3512593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Kato K; Shima K
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
    Seki K; Kato K
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1138-41. PubMed ID: 3932450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four hour secretory pattern of growth hormone in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Kato K; Shima K
    Endocrinol Jpn; 1987 Feb; 34(1):129-32. PubMed ID: 3608911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient appearance of a provocative growth hormone response to L-dopa following incomplete adenomectomy in an acromegalic patient.
    Takahara J; Yakushiji W; Yamuchi J; Miyoshi M; Hosogi H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):599-602. PubMed ID: 838854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
    Cremonini N; Graziano E; Chiarini V; Sforza A; Zampa GA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1166-9. PubMed ID: 1400888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of using parlodel in hyperprolactinemia].
    Mel'nichenko GA; Gitel' EP; Romantsova TI
    Probl Endokrinol (Mosk); 1990; 36(3):29-33. PubMed ID: 2395828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of growth hormone to metoclopramide in normal women and amenorrheic women with or without hyperprolactinemia.
    Seki K; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):721-5. PubMed ID: 3830074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline.
    Arosio M; Moriondo P; Travaglini P; Ambrosi B; Beck-Peccoz P; Puglisi FC; Secchi F; Faglia G
    J Clin Endocrinol Metab; 1980 Sep; 51(3):454-61. PubMed ID: 6773973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of glucose and insulin during twenty-four hours in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Nagata I
    Gynecol Obstet Invest; 1991; 31(4):222-5. PubMed ID: 1885092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis of hyperprolactinemia].
    Takeda R; Minagawa F; Nakabayashi H
    Nihon Rinsho; 1986 Mar; 44(3):671-7. PubMed ID: 2874247
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
    Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
    Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Ayalon D; Eckstein N; Avidan S; Eshel A; L'Hermite M; Caufriez A; Spitz I; Zylber-Haran E
    Gynecol Obstet Invest; 1983; 16(2):97-106. PubMed ID: 6413305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.